Search is Powered by Google
Follow us on:
Follow our health news on Twitter
Follow Our News on Facebook
Personalization
login | register
Depression News

Depressive Symptoms Related To Menopause Eased By Omega-3s

Main Category: Depression
Also Included In: Menopause;  Nutrition / Diet;  Psychology / Psychiatry
Article Date: 29 Jan 2009 - 7:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions


Current Article Ratings:

Patient / Public:4 and a half stars

4.5 (4 votes)

Health Professional:5 stars

4.67 (3 votes)

Article Opinions: 0 posts

Omega-3s ease psychological distress and depressive symptoms often suffered by menopausal and perimenopausal women, according to researchers at Université Laval's Faculty of Medicine. Their study, published in the February issue of The American Journal of Clinical Nutrition, presents the first evidence that omega-3 supplements are effective for treating common menopause-related mental health problems.

Dr. Michel Lucas and colleagues recruited 120 women age 40 to 55 and divided them into two groups. Women in the first group took three gel capsules containing a total of one gram of EPA, an omega-3 fatty acid of marine origin, every day for eight weeks. Those in the second group followed the same protocol, but took gel capsules containing sunflower oil without EPA.

Test results before and after the eight-week period indicate that omega-3s significantly improved the condition of women suffering symptoms of psychological distress and mild depression. "The differences we observed between the two groups are noteworthy," commented Dr Lucas, "especially considering that omega-3s have very few side effects and are beneficial to cardiovascular health." However, no positive effect was observed among a small group of women with more severe depressive symptoms.

Women with hot flashes also noted that their condition improved after consuming omega-3s. At baseline, the number of daily hot flashes was 2.8 and dropped by an average of 1.6 in the group taking omega-3s and by 0.5 in the control group. The change that can be attributed to the use of omega-3s, i.e. a decrease of 1.1 hot flashes per day, is equivalent to results obtained with hormone therapy and antidepressants. Details of these results were published in the November 20, 2008 online edition of the journal Menopause.

Many women suffer from depressive symptoms during menopause and perimenopause. Some take antidepressants for relief even though their effectiveness is controversial. Mistrust of hormone therapy and antidepressants leads certain women to turn to alternative methods whose effectiveness has not yet been scientifically demonstrated. This study by Université Laval researchers corrects this situation with regard to marine-sourced omega-3s.

----------------------------
Article adapted by Medical News Today from original press release.
----------------------------

The following researchers coauthored this study with Michel Lucas: Geneviève Asselin and Sylvie Dodin from the Lucie and André Chagnon Chair for the Teaching of an Integrated Approach in Prevention, as well as Chantal Mérette and Marie-Josée Poulin from Université Laval Robert-Giffard Research Center.

Source: Jean-François Huppé
Université Laval




Personalized Homepage Weekly Newsletters Daily News Alerts
Hemophilia Opioid Induced Constipation Pneumococcal Disease ADHD Anxiety Asthma Atrial Fibrillation Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Haiti Appeal

Haiti Appeal Image
The severe earthquake that struck Haiti has inflicted damage and devastation on a massive scale. Please donate to the Doctors Without Borders Haiti Appeal.

PLEASE DONATE HERE


These are the most read articles from this news category for the last 6 months:
Top Article Star
Targacept Presents Data From Highly Successful Phase 2b Trial Of TC-5214 As Augmentation Treatment For Major Depressive Disorder
16 Oct 2009
Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics™, today announced the presentation of data from its recently completed Phase 2b...


Seasonal Depression image Seasonal Depression

Every winter, when the days get shorter, people with seasonal affective disorder, also known as SAD, experience depression. Learn how light can help chase away the winter blues...

Treating Major Depression image Treating Major Depression

Major depression is more than just suffering from a bad mood. It can affect just about everything you do, from how you sleep at night to how well you perform your job. Learn how you can feel better...

View more videos...